Medicalgorithmics (WAR:MDG) Total Stockholders Equity: zł62.92 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:MDG Medicalgorithmics SA WAR:MDG
71 GF Score
Price zł25.50
GF Value zł29.15
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Medicalgorithmics Total Stockholders Equity?

Medicalgorithmics WAR:MDG 71 Total Stockholders Equity is zł62.92 Mil as of Mar. 2026. GuruFocus rates WAR:MDG with a GF Score™ of 71/100 and a GF Value™ of zł29.15 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Medicalgorithmics's Total Stockholders Equity for the quarter that ended in Mar. 2026 was zł62.92 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Medicalgorithmics's Book Value per Share for the quarter that ended in Mar. 2026 was zł6.32. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Medicalgorithmics's Debt-to-Equity for the quarter that ended in Mar. 2026 was 0.41.

Medicalgorithmics  (WAR:MDG) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Medicalgorithmics's Book Value per Share for the quarter that ended in Mar. 2026 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(62.916-0)/9.952769
=6.32

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Medicalgorithmics's Debt-to-Equity for the quarter that ended in Mar. 2026 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(4.52 + 21.087) / 62.916
=0.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medicalgorithmics Total Stockholders Equity Related Terms

Medicalgorithmics Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Medicalgorithmics's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medicalgorithmics Total Stockholders Equity Chart

Medicalgorithmics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 47.39 94.67 92.56 77.17 64.62

Medicalgorithmics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 72.63 69.70 65.88 64.62 62.92
WAR:MDG
71GF Score
Medicalgorithmics SA WAR:MDG
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of zł62.92 Mil mean?
Medicalgorithmics (WAR:MDG) has a Total Stockholders Equity of zł62.92 Mil as of Mar. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Medicalgorithmics and its competitors.
Is Medicalgorithmics' Total Stockholders Equity too high?
Medicalgorithmics' current Total Stockholders Equity is zł62.92 Mil. Overall, Medicalgorithmics has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medicalgorithmics' Total Stockholders Equity compare to ABT and SYK?
Medicalgorithmics' Total Stockholders Equity of zł62.92 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Medical Devices & Instruments company?
A good Total Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Medicalgorithmics and its competitors. Medicalgorithmics's current Total Stockholders Equity is zł62.92 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicalgorithmics stock overvalued right now?
Based on GuruFocus' analysis, Medicalgorithmics (WAR:MDG) is currently considered Modestly Undervalued. The stock's GF Value™ is zł29.15, compared to a current price of zł25.50 — trading 12.5% below its estimated fair value. The current Total Stockholders Equity is zł62.92 Mil. Medicalgorithmics' overall GF Score™ is 71/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Medicalgorithmics (WAR:MDG), the current Total Stockholders Equity is zł62.92 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medicalgorithmics (WAR:MDG) Overvalued in 2026?

Based on GuruFocus' analysis, Medicalgorithmics stock appears to be undervalued. The current stock price of zł25.50 is trading 12.5% below its estimated GF Value™ of zł29.15. GuruFocus considers Medicalgorithmics to be Modestly Undervalued.

Key valuation signals for WAR:MDG:

  • Total Stockholders Equity: zł62.92 Mil
  • GF Value™: zł29.15 vs. price of zł25.50 (12.5% below fair value)
  • GF Score™: 71/100 with 4 warning signs

No single metric tells the full story. See the WAR:MDG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medicalgorithmics Business Description

Address Al Jerozolimskie 81, 19 Floor, Central Tower Building, Warsaw, POL, 02-001
Medicalgorithmics SA is a medical technology company. It is engaged in the development of Digital Signal Processing (DSP) algorithms development and software and hardware electronics design for medical applications. The company specializes in providing advance technological solutions in the field of cardiac diagnostics, with a particular focus on ECG signal analysis. The group concentrates on the production and development of its flagship product Pocket ECG - a system for remote monitoring of cardiac arrhythmias. The offered solutions include algorithms and diagnostic systems used in remote heart monitoring. The company operates in Poland, the USA, and other, with majority of revenue from the USA.
71GF Score

Get the complete analysis for WAR:MDG

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł25.50
Price
zł29.15
GF Value